medigraphic.com
ISSN 0035-0052 (Print)

2009, Number 1

<< Back

Rev Mex Pediatr 2009; 76 (1)

Obesity in the childhood: The pandemy

Ortiz ROE

Language: Spanish
References: 31
Page: 38-43
PDF size: 128.48 Kb.


ABSTRACT

The worldwide problem of obesity in children has become a public health problem and actually is considered a global epidemic. Prevalence is continuing to rise. In developed world obesity is now the most common disease of childhood and adolescence. Is not a cosmetic issue, but is resulting in chronic diseases previously seen in adult life. Our country has become to be the 2nd place of childhood obesity in worldwide. Is important to have more systemic review and cause impact in health professionals for better earlier interventions.


REFERENCES

  1. Reilly JJ. Obesity in childhood and adolescence: evidence based clinical and public health perspectives. Postgrad Med J 2006; 82: 429-37.

  2. Troyano RP, Flegal KN. Overweight in children and adolescents. Description, epidemiology and demographics. Pediatrics 1998; 101: 497-504.

  3. Brown M, Sibile K. Obesity in children and adolescents. Clin Family Practice 2002; 4(3): 1-14.

  4. Must A. Effects of obesity on morbidity in children and adolescents. Nutr Clin Care 2003; 6(1): 4-12.

  5. Ebbeling C, Pawiak D, Ludwig DS. Childhood obesity: public- health crisis, common sense cure. Lancet 2002; 360(9331): 473-82.

  6. Sokol R. The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr 2000; 136(6): 711-3.

  7. Styne DM. Childhood and adolescent obesity. Prevalence and significance. Pediatr Clin North Am 2001; 48(4): 823-54.

  8. Roberts SB, Savage J, Coward WA, Chew B, Lucas A. Energy expenditure and intake in infants born to lean and overweight mothers. N Engl J Med 1988; 318(1): 461-466.

  9. Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, González-de Cossío T, Hernández-Prado B, Sepúlveda J. Encuesta Nacional de Nutrición 1999. Estado nutricio de niños y mujeres en México. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2001.

  10. Shamah-Levy T, Villalpando-Hernández S, Rivera-Dommarco JA. Resultados de Nutrición de la ENSANUT 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2007.

  11. Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F et al. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 2006; 155(5): 735-43.

  12. Pombo AM. Tratado de endocrinología pediátrica. 3a ed. Madrid: Mc Graw-Hill. 2002.

  13. Arya R, Duggirala R, Jenkinson C, Almasy L, Blangero J, O’Connell P et al. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. Am J Hum Genet 2004; 74: 272-282.

  14. Yetman R. Evaluation and management of obesity in children and adolescents. J Pediatr Health Care 2004; 18(1): 35-8.

  15. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116(7): 1802-12.

  16. Li C, Ford ES, Mokdad AH, Cook SA. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 2006; 118(5): e1390-8.

  17. Sartorio A, Del Col A, Agosti F et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2006; 61(7): 877-83.

  18. Chiolero A, Madeleine G, Gabriel A, Burnier M, Paccaud F, Bovet P. Prevalence of elevated blood pressure and association with overweight in children of a rapidly developing country. J Hum Hypertens 2006; 21(2): 120-7.

  19. Dessprés JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334(15): 952-7.

  20. Burke V. Obesity in childhood and cardiovascular risk. Clin Exp Pharmacol Physiol 2006; 33(9): 831-7.

  21. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation 2001; 104(23): 28 15-19.

  22. Mantzoros CS, Flier JS. Insulin resistance: the clinical spectrum. Adv Endocrinol Metab 1995; 6: 193-232.

  23. Wallace WJ, Sheslow D, Hassink S. Obesity in children: a risk for depression. Ann N Y Acad Sci 1993; 699: 301-3.

  24. Gortmaker SL, Petersen K, Wiecha J, Sobol SM, Dixit S, Fix MK et al. Reducing obesity via a school-based interdisciplinary intervention among youth: Planet health. Arch Pediatr Adolesc Med 1999; 153: 409-18.

  25. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. Pediatrics 1998; 102(3): E29.

  26. Epstein LH, Myers MD, Raynor HA et al. Treatment of pediatric obesity. Pediatr Adolesc Med 1998; 101(3pt2): 554-70.

  27. Padwal R, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007; 369(9555): 71-7.

  28. Padwal R, Li SK, Lau DC. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0467 (tetrahydrolipstatin). Am J Clin Nutr 1992; 55: 309.

  29. Padwal RS, Li SK, Lau DC. Long term pharmacotherapy for obesity and overweight. Int J Obes Relat Metab Disord 2003; 27(12): 1437-46.

  30. McNeely W, Goa KL. Sibutramine. A review of its contribution to the management of obesity. Drugs 1998; 56(6): 1093-124.

  31. Curioni C, André C. Rimonabant for overweight for obesity. Cochrane Database Sys Rev 2006; 4: CD006162




2020     |     www.medigraphic.com